Literature DB >> 24892128

Objective benefits, participant perceptions and retention rates of a New Zealand community-based, older-adult exercise programme.

Justin W Keogh1, John Rice2, Denise Taylor3, Andrew Kilding4.   

Abstract

INTRODUCTION: Most exercise studies for older adults have been university- or hospital-based. Little is known about the benefits and factors influencing long-term participation in community-based exercise programmes, especially in New Zealand. AIM: To quantify the objective benefits, participant perceptions and retention rates of a New Zealand community-based exercise programme for adults (60 years or older).
METHODS: Study 1 involved assessing the benefits of 12 weeks' training on a convenience sample of 62 older adults commencing the never2old Active Ageing programme. Study 2 assessed the perceptions of 150 current participants on a variety of programme components that could act as barriers or facilitators to continued engagement. Study 3 assessed the retention rates of 264 participants in the programme over a two-year period.
RESULTS: Significant improvements in many physical functional scores were observed in Study 1 (5-30 percentile points; p<0.05). Questionnaire responses from participants in Study 2 indicated many perceived benefits (positive responses from 67-95% on various questions) and that core components of the programme were rated very highly (64-99% on various components). Retention rates were high, with Study 3 finding 57% of participants still engaging in the programme at the end of the two-year period. DISCUSSION: A community-based exercise programme for older adults can improve many objective and subjective measures of physical fitness and functional performance and have good retention rates. General practitioners and other allied health professionals in New Zealand should consider promoting programmes, such as the never2old Active Ageing programme, to their older patients.

Entities:  

Mesh:

Year:  2014        PMID: 24892128

Source DB:  PubMed          Journal:  J Prim Health Care        ISSN: 1172-6156


  7 in total

1.  ACE and UCP2 gene polymorphisms and their association with baseline and exercise-related changes in the functional performance of older adults.

Authors:  Justin W L Keogh; Barry R Palmer; Denise Taylor; Andrew E Kilding
Journal:  PeerJ       Date:  2015-05-28       Impact factor: 2.984

Review 2.  Clinical Screening Tools for Sarcopenia and Its Management.

Authors:  Solomon C Y Yu; Kareeann S F Khow; Agathe D Jadczak; Renuka Visvanathan
Journal:  Curr Gerontol Geriatr Res       Date:  2016-02-04

3.  Older people's adherence to community-based group exercise programmes: a multiple-case study.

Authors:  Clare Killingback; Fotini Tsofliou; Carol Clark
Journal:  BMC Public Health       Date:  2017-01-25       Impact factor: 3.295

4.  Why do seniors leave resistance training programs?

Authors:  Elissa Burton; Anne-Marie Hill; Simone Pettigrew; Gill Lewin; Liz Bainbridge; Kaela Farrier; Phil Airey; Keith D Hill
Journal:  Clin Interv Aging       Date:  2017-03-27       Impact factor: 4.458

Review 5.  Review of how we should define (and measure) adherence in studies examining older adults' participation in exercise classes.

Authors:  H Hawley-Hague; M Horne; D A Skelton; C Todd
Journal:  BMJ Open       Date:  2016-06-23       Impact factor: 2.692

6.  The Effect of Nordic Walking Training with Poles with an Integrated Resistance Shock Absorber on the Functional Fitness of Women over the Age of 60.

Authors:  Katarzyna Marciniak; Janusz Maciaszek; Magdalena Cyma-Wejchenig; Robert Szeklicki; Zuzanna Maćkowiak; Dorota Sadowska; Rafał Stemplewski
Journal:  Int J Environ Res Public Health       Date:  2020-03-25       Impact factor: 3.390

7.  The Effect of Nordic Walking Training with Poles with an Integrated Resistance Shock Absorber on the Body Balance of Women over the Age of 60.

Authors:  Katarzyna Marciniak; Janusz Maciaszek; Magdalena Cyma-Wejchenig; Robert Szeklicki; Rafał Stemplewski
Journal:  Healthcare (Basel)       Date:  2021-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.